Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Executive Changes (Jan 7, 2026)

Reports
Leadership Changes
Filing Date
Filed January 7, 2026
Period End
January 1, 2026
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Jan ’25Jan ’25

Summary

Summary of the 8-K filed January 7, 2026. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. reported in this Form 8-K, dated January 7, 2026, that effective January 1, 2026 it entered into amendments to the employment agreements of each of its named executive officers.

The amendments extend each agreement's term by one year to December 31, 2028 and revise annual salaries following the annual review by the Compensation Committee of the Board of Directors. The filing states that the amendments also included material changes for Matthew Gourmand, President, and Gail Makode, Chief Legal Officer and General Counsel. For Mr. Gourmand, the filing states that the annual bonus opportunity was increased to 200%a of base salary at the high level of performance (from 125%), 125% at target (from 75%), and 75% at threshold (from 50%).

Severance upon termination without cause or for good reason, as defined in the agreement, rises from two times the sum of annual base salary and the three-year average annual bonus to three times that sum, payable over three years. His post-termination non-competition and non-solicitation covenants were extended from two years to three years.

For Ms. Makode, the filing states that severance upon termination without cause or for good reason increases from one and a half times to two times the sum of annual base salary and the three-year average annual bonus, payable over two years, and her post-termination restrictive covenants were extended from 18 months to two years. The full text of the form of amendment is to be filed as an exhibit to the Company's Form 10-Q for the first quarter of 2026.

Key Highlights

  1. Employment agreements of all named executive officers extended by one year to December 31, 2028, effective January 1, 2026.
  2. Annual salaries of named executive officers revised following the Compensation Committee's annual review.
  3. Matthew Gourmand (President): high-level bonus opportunity raised from 125% to 200% of base salary; target raised from 75% to 125%; threshold raised from 50% to 75%.
  4. Matthew Gourmand: severance multiple increased from two times to three times the sum of base salary and three-year average annual bonus, payable over three years.
  5. Matthew Gourmand: post-termination non-competition and non-solicitation restrictions extended from two years to three years.
  6. Gail Makode (Chief Legal Officer and General Counsel): severance multiple increased from one and a half times to two times the sum of base salary and three-year average annual bonus, payable over two years.
  7. Gail Makode: post-termination restrictive covenants extended from 18 months to two years.

Frequently Asked Questions

  1. What changed in the executive employment agreements?

    As of January 1, 2026, the Company amended the employment agreements of each named executive officer to extend their terms by one year to December 31, 2028 and to revise annual salaries following the Compensation Committee's annual review.

  2. What are the most significant changes for Matthew Gourmand?

    His bonus opportunity increased to 200% of base salary at the high level of performance, 125% at target and 75% at threshold, from 125%, 75% and 50% respectively. His severance multiple rose from two times to three times the sum of base salary and three-year average annual bonus, payable over three years, and his non-compete and non-solicitation periods were extended from two to three years.

  3. What changed in Gail Makode's agreement?

    Her severance multiple increased from one and a half times to two times the sum of annual base salary and three-year average annual bonus, payable over two years, and her post-termination restrictive covenants were extended from 18 months to two years.

  4. Where can the full terms of the amendments be found?

    The filing states that the full text of the form of employment agreement amendment will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the first quarter of 2026.